Close
4

Seqens Seqens

X

Company profile for Cerveau Technologies

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
In 2016, Cerveau was formed to advance MK-6240 into the mainstream of neurodegenerative disease research. Since then, MK-6240 has become an acknowledged leading imaging biomarker for Tau pathologies, central to AD progression. Cerveau licensed MK-6240 from Merck and committed to establish a broad network of production facilities to support clinical research. Through the Cerveau Users Group, Pharma companies and leading Acad...
In 2016, Cerveau was formed to advance MK-6240 into the mainstream of neurodegenerative disease research. Since then, MK-6240 has become an acknowledged leading imaging biomarker for Tau pathologies, central to AD progression. Cerveau licensed MK-6240 from Merck and committed to establish a broad network of production facilities to support clinical research. Through the Cerveau Users Group, Pharma companies and leading Academic centers gain access to MK-6240 for their cutting edge research, share non-competitive data with the entire Users Group and disclose breakthrough science as appropriate.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Cerveau Technologies
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
308 N. Peters Road Suite #201 Knoxville, TN 37922
Telephone
Telephone
(865) 868-3402
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY